Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 129

Similar articles for PubMed (Select 21993403)

1.

Node-negative T1-T2 anal cancer: radiotherapy alone or concomitant chemoradiotherapy?

Zilli T, Schick U, Ozsahin M, Gervaz P, Roth AD, Allal AS.

Radiother Oncol. 2012 Jan;102(1):62-7. doi: 10.1016/j.radonc.2011.09.015. Epub 2011 Oct 10.

PMID:
21993403
2.

Elective inguinal node irradiation in early-stage T2N0 anal cancer: prognostic impact on locoregional control.

Zilli T, Betz M, Bieri S, Ris F, Roche B, Roth AD, Allal AS.

Int J Radiat Oncol Biol Phys. 2013 Sep 1;87(1):60-6. doi: 10.1016/j.ijrobp.2013.03.008. Epub 2013 Apr 19.

PMID:
23608237
3.

Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.

Jin J, Liao Z, Zhang Z, Ajani J, Swisher S, Chang JY, Jeter M, Guerrero T, Stevens CW, Vaporciyan A, Putnam J Jr, Walsh G, Smythe R, Roth J, Yao J, Allen P, Cox JD, Komaki R.

Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):427-36.

PMID:
15380576
4.
5.

[Epidermoid carcinomas of the anal canal treated with definitive radiation therapy in a series of 305 patients].

Deniaud-Alexandre E, Touboul E, Tiret E, Sezeur A, Houry S, Gallot D, Parc R, Huang R, Qu SH, Pène F, Schlienger M.

Cancer Radiother. 2003 Aug;7(4):237-53. French.

PMID:
12914857
6.

Experience with split-course external beam irradiation +/- chemotherapy and integrated Ir-192 high-dose-rate brachytherapy in the treatment of primary carcinomas of the anal canal.

Kapp KS, Geyer E, Gebhart FH, Oechs AC, Berger A, Hebenstreit J, Stoeger H.

Int J Radiat Oncol Biol Phys. 2001 Mar 15;49(4):997-1005.

PMID:
11240240
7.

Squamous cell carcinoma of the anal margin: the university of Florida experience.

Balamucki CJ, Zlotecki RA, Rout WR, Newlin HE, Morris CG, Kirwan JM, George TJ Jr, Mendenhall WM.

Am J Clin Oncol. 2011 Aug;34(4):406-10. doi: 10.1097/COC.0b013e3181e9c0c0.

PMID:
20881476
8.

Chemoradiotherapy of anal carcinoma: survival and recurrence in an unselected national cohort.

Bentzen AG, Guren MG, Wanderås EH, Frykholm G, Tveit KM, Wilsgaard T, Dahl O, Balteskard L.

Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):e173-80. doi: 10.1016/j.ijrobp.2011.12.062. Epub 2012 Mar 19.

PMID:
22436791
9.

Tumor site predicts outcome after radiochemotherapy in squamous-cell carcinoma of the anal region: long-term results of 101 patients.

Grabenbauer GG, Kessler H, Matzel KE, Sauer R, Hohenberger W, Schneider IH.

Dis Colon Rectum. 2005 Sep;48(9):1742-51.

PMID:
15991058
10.

[Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)].

Deniaud-Alexandre E, Touboul E, Tiret E, Sezeur A, Hannoun L, Houry S, Huguet F, Pène F, Parc R, Schlienger M.

Cancer Radiother. 2006 Dec;10(8):572-82. Epub 2006 Nov 15. French.

PMID:
17110148
12.

Combined chemoradiation therapy for anal cancer. A report of 56 cases.

Doci R, Zucali R, Bombelli L, Montalto F, Lamonica G.

Ann Surg. 1992 Feb;215(2):150-6.

13.

Radiotherapy for epidermoid carcinoma of the anus: thirty years' experience.

Myerson RJ, Outlaw ED, Chang A, Birnbaum EH, Fleshman JW, Grigsby PW, Kodner IJ, Malayapa RS, Mutch MG, Parikh P, Picus J, Tan BR.

Int J Radiat Oncol Biol Phys. 2009 Oct 1;75(2):428-35. doi: 10.1016/j.ijrobp.2008.11.047. Epub 2009 Feb 27.

PMID:
19251377
14.

[Prognosis of epidermoid anal carcinoma regression after conservative treatment].

Vorob'ëv GI, Odariuk TS, Orlova LP, Nechushkin MI, Rybakov EG.

Vopr Onkol. 2004;50(6):663-7. Russian.

PMID:
15755059
15.

Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes.

Klas JV, Rothenberger DA, Wong WD, Madoff RD.

Cancer. 1999 Apr 15;85(8):1686-93. Review.

PMID:
10223561
16.

Epidermal growth factor receptor expression as prognostic marker in patients with anal carcinoma treated with concurrent chemoradiation therapy.

Fraunholz I, Rödel F, Kohler D, Diallo-Georgiopoulou M, Distel L, Falk S, Rödel C.

Int J Radiat Oncol Biol Phys. 2013 Aug 1;86(5):901-7. doi: 10.1016/j.ijrobp.2013.03.039. Epub 2013 Jun 5.

PMID:
23755922
17.

Chemoradiotherapy with capecitabine for locally advanced anal carcinoma: an alternative treatment option.

Meulendijks D, Dewit L, Tomasoa NB, van Tinteren H, Beijnen JH, Schellens JH, Cats A.

Br J Cancer. 2014 Oct 28;111(9):1726-33. doi: 10.1038/bjc.2014.467. Epub 2014 Aug 28.

PMID:
25167226
18.

Twenty-five-year experience with radical chemoradiation for anal cancer.

Tomaszewski JM, Link E, Leong T, Heriot A, Vazquez M, Chander S, Chu J, Foo M, Lee MT, Lynch CA, Mackay J, Michael M, Tran P, Ngan SY.

Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):552-8. doi: 10.1016/j.ijrobp.2011.07.007. Epub 2011 Oct 21.

PMID:
22019078
19.

Treatment results and prognostic factors of advanced T3--4 laryngeal carcinoma: the University of California, San Francisco (UCSF) and Stanford University Hospital (SUH) experience.

Nguyen-Tan PF, Le QT, Quivey JM, Singer M, Terris DJ, Goffinet DR, Fu KK.

Int J Radiat Oncol Biol Phys. 2001 Aug 1;50(5):1172-80.

PMID:
11483326
20.

The impact of treatment factors on local control in T2-T3 anal carcinomas treated by radiotherapy with or without chemotherapy.

Allal AS, Mermillod B, Roth AD, Marti MC, Kurtz JM.

Cancer. 1997 Jun 15;79(12):2329-35.

PMID:
9191520
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk